Insider Trading & Ownership - ROSS GEORGE K

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for ROSS GEORGE K

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-01-02
Option Award
2025-01-24
4:44 pm
N/A
N/A
ACURA PHARMACEUTICALS INC ACUR ROSS GEORGE K
Director
50,000 $0 595,503
(Direct)
View
2025-01-02
Exercise
2025-01-24
4:44 pm
N/A
N/A
ACURA PHARMACEUTICALS INC ACUR ROSS GEORGE K
Director
50,000 $0 595,503
(Direct)
View
2024-01-02
Option Award
2024-01-02
3:23 pm
N/A
N/A
ACURA PHARMACEUTICALS INC ACUR ROSS GEORGE K
Director
50,000 $0 545,503
(Direct)
View
2024-01-02
Exercise
2024-01-02
3:23 pm
N/A
N/A
ACURA PHARMACEUTICALS INC ACUR ROSS GEORGE K
Director
50,000 $0 545,503
(Direct)
View
2023-01-03
Option Award
2023-01-05
4:06 pm
N/A
N/A
ACURA PHARMACEUTICALS INC ACUR ROSS GEORGE K
Director
50,000 $0 495,503
(Direct)
View
2023-01-03
Exercise
2023-01-05
4:06 pm
N/A
N/A
ACURA PHARMACEUTICALS INC ACUR ROSS GEORGE K
Director
66,666 $0 495,503
(Direct)
View
2022-01-03
Option Award
2022-01-10
4:11 pm
N/A
N/A
ACURA PHARMACEUTICALS INC ACUR ROSS GEORGE K
Director
66,666 $0 445,503
(Direct)
View
2022-01-03
Exercise
2022-01-10
4:11 pm
N/A
N/A
ACURA PHARMACEUTICALS INC ACUR ROSS GEORGE K
Director
66,666 $0 445,503
(Direct)
View
2021-05-25
Option Award
2021-05-28
4:12 pm
N/A
N/A
ACURA PHARMACEUTICALS INC ACUR ROSS GEORGE K
Director
66,666 $0 66,666
(Direct)
View
2021-01-04
Exercise
2021-01-06
4:12 pm
N/A
N/A
ACURA PHARMACEUTICALS INC ACUR ROSS GEORGE K
Director
54,790 $0 312,171
(Direct)
View